EVIDENCE THAT PGF(2-ALPHA)-INDUCED CONTRACTION OF ISOLATED GUINEA-PIG BRONCHI IS MEDIATED IN PART BY RELEASE OF TACHYKININS

被引:9
作者
FUJII, K [1 ]
KOHROGI, H [1 ]
IWAGOE, H [1 ]
HAMAMOTO, J [1 ]
HIRATA, N [1 ]
YAMAGUCHI, T [1 ]
KAWANO, O [1 ]
ANDO, M [1 ]
机构
[1] KUMAMOTO UNIV,SCH MED,DEPT INTERNAL MED 1,KUMAMOTO 860,JAPAN
关键词
SUBSTANCE P; ASTHMA; COUGH; CAPSAICIN; PROSTAGLANDIN F2-ALPHA;
D O I
10.1152/jappl.1995.79.5.1411
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
To investigate whether prostaglandin F-2 alpha (PGF(2 alpha)) stimulates the release of tachykinins and whether the tachykinins play a role in the PGF(alpha 2)-induced bronchial contraction, we examined the contractile response to PGF(2 alpha) in the presence or absence of a neutral endopeptidase (NEP) inhibitor phosphoramidon in the guinea pig main bronchus in vitro. Because NEP effectively cleaves tachykinins, we hypothesized that the inhibition of NEP would enhance a PGF(2 alpha)-induced bronchial contraction if PGF(2 alpha) stimulates the release of tachykinins. Phosphoramidon significantly enhanced the concentration-response curve to PGF(2 alpha). And it also significantly enhanced 10(-5) M PGF(2 alpha)-induced contraction. The enhancement was significantly attenuated in tissues where the tachykinins had been depleted by treatment with capsaicin. Furthermore, the enhancement of contraction was also significantly attenuated in the presence of tachykinin antagonist FK-224 (10(-5) M). Tetrodotoxin, a sodium-channel blocker that blocks nerve conduction, did not affect the enhancement. From these results we conclude that 1) PGF(2 alpha) causes the release of tachykinin-like substances, 2) these substances play a role in bronchial contraction in tissues where NEP activity is inhibited, and 3) nerve conduction is not necessary for the release of these substances in the guinea pig bronchus.
引用
收藏
页码:1411 / 1418
页数:8
相关论文
共 41 条
[1]  
BARNES PJ, 1986, LANCET, V1, P242
[2]   NEUTRAL ENDOPEPTIDASE AND NEUROGENIC INFLAMMATION IN RATS WITH RESPIRATORY-INFECTIONS [J].
BORSON, DB ;
BROKAW, JJ ;
SEKIZAWA, K ;
MCDONALD, DM ;
NADEL, JA .
JOURNAL OF APPLIED PHYSIOLOGY, 1989, 66 (06) :2653-2658
[3]  
BORSON DB, 1987, EXP LUNG RES, V13, P21
[4]  
BUCK SH, 1986, PHARMACOL REV, V38, P179
[5]   CYCLOOXYGENASE METABOLISM OF ENDOGENOUS ARACHIDONIC-ACID BY CULTURED HUMAN TRACHEAL EPITHELIAL-CELLS [J].
CHURCHILL, L ;
CHILTON, FH ;
RESAU, JH ;
BASCOM, R ;
HUBBARD, WC ;
PROUD, D .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 140 (02) :449-459
[6]   STIMULATION OF IRRITANT RECEPTORS AND AFFERENT C-FIBERS IN LUNGS BY PROSTAGLANDINS [J].
COLERIDGE, HM ;
COLERIDGE, JCG ;
GINZEL, KH ;
BAKER, DG ;
BANZETT, RB ;
MORRISON, MA .
NATURE, 1976, 264 (5585) :451-453
[7]   NONADRENERGIC, NONCHOLINERGIC CONTRACTIONS IN THE ELECTRICALLY FIELD STIMULATED GUINEA-PIG TRACHEA [J].
ELLIS, JL ;
UNDEM, BJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 101 (04) :875-880
[8]  
FRANCOCERECEDA A, 1989, N-S ARCH PHARMACOL, V340, P180
[9]   SENSORY NEUROPEPTIDE RELEASE BY BRADYKININ - MECHANISMS AND PATHOPHYSIOLOGICAL IMPLICATIONS [J].
GEPPETTI, P .
REGULATORY PEPTIDES, 1993, 47 (01) :1-23
[10]  
GEPPETTI P, 1991, J PHARMACOL EXP THER, V259, P759